Status:
COMPLETED
Rickettsiae in Myanmar
Lead Sponsor:
Myanmar Oxford Clinical Research Unit
Collaborating Sponsors:
National Health Laboratory, Myanmar
Magway General Hospital, Magway
Conditions:
Rickettsiae Infections
Eligibility:
All Genders
Brief Summary
Rickettsial infections have been found to be the second most common cause of non-malarial febrile illness in Southeast Asia, just after dengue, and are largely neglected treatable causes of morbidity ...
Detailed Description
Rickettsial infections have been found to be the second most common cause of non-malarial febrile illness in Southeast Asia, just after dengue, and are largely neglected treatable causes of morbidity ...
Eligibility Criteria
Inclusion
- Male and female, all age groups, requiring a blood draw for a routine clinical purpose
Exclusion
- Leftover blood sample of less than 500μL
Key Trial Info
Start Date :
June 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 25 2019
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03847870
Start Date
June 20 2019
End Date
October 25 2019
Last Update
January 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Myanmar Oxford Clinical Research Unit
Yangon, Burma